Aramark Insider Filing: 62.2 Shares Credited to Director Lopez (Form 4)

Rhea-AI Filing Summary

Patricia E. Lopez, a director of Aramark (ARMK), acquired 62.2 shares on 08/20/2025 through dividend equivalent rights that vested on deferred stock units she holds. The reported transaction shows a $0 per-share price and leaves the reporting person with 23,792.883 shares beneficially owned in a direct form. The filing clarifies these were dividend equivalent rights tied to the issuer's quarterly dividend and that such rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

Positive

• 62.2 shares acquired via dividend equivalent rights on 08/20/2025, indicating continued equity alignment with the company
• Beneficial ownership reported post-transaction: 23,792.883 shares, showing transparency of insider holdings

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity accrual from dividend equivalents; governance signal is neutral.

The Form 4 records a non-cash acquisition of 62.2 shares via dividend equivalent rights that vest with deferred stock units. This is a common compensation mechanism aligning director interests with shareholders without indicating any change in role or control. The direct beneficial ownership after the transaction is 23,792.883 shares, which provides continued alignment but is not a material shift in ownership percentage for a public company the size of Aramark.

Securities Analyst

TL;DR: Non-derivative, zero-cost share accrual; immaterial to valuation but confirms ongoing equity compensation.

The entry shows a transaction code for acquisition and a $0 price, consistent with dividend equivalents credited to deferred awards. Such entries do not reflect market purchases or sales and therefore have negligible immediate impact on float or liquidity. The update is useful for monitoring insider ownership trends over time but is not a material corporate action.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOPEZ PATRICIA E

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		62.2(1)	A	$0	23,792.883	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Patricia E. Lopez report on her Form 4 for ARMK?

The Form 4 reports an acquisition of 62.2 shares on 08/20/2025 via dividend equivalent rights and a resulting beneficial ownership of 23,792.883 shares.

Was any cash paid for the shares reported on the Form 4 (ARMK)?

No. The transaction lists a price of $0, reflecting dividend equivalent rights credited to deferred stock units.

What is the nature of the securities acquired by the reporting person?

They are common stock acquired as dividend equivalent rights tied to deferred stock units that vest on the same schedule as the underlying awards.

Does the Form 4 indicate a change in the reporting person's role at Aramark (ARMK)?

No. The form indicates the reporting person is a Director and does not show any change in relationship to the issuer.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by Ryan S. Spengler, as Attorney-in-fact on 08/21/2025.